ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Psychiatry

Top Psychiatry Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOUNIR SOLIMAN M.D.

Psychiatry

340

$22K

65
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

54%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $143

DAVID LEHMAN M.D.

Psychiatry

1,939

$143K

114
95 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $143

ERIK PASCHALL M.D., M.P.H.

Psychiatry

5,421

$276K

539
423 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $143

LAWRENCE MCGLYNN M.D., M.S.

Psychiatry

1,974

$382K

95
0 are 65+

48%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 25%

$194
Average prescription price

Avg: $143

TERESA SANDOVAL-PHILLIPS M.D.

Psychiatry

2,513

$134K

399
311 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $143

MICHAEL TORRENTE DO

Psychiatry

1,873

$185K

76
12 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $143

ALLISON BOTWIN M.D.

Psychiatry

2,635

$284K

107
44 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $143

THOMAS CURTIS M.D.

Psychiatry

638

$31.9K

71
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $143

TERRENCE EARLY MD

Psychiatry

1,351

$163K

85
25 are 65+

26%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $143

KURTIS LINDEMAN M.D.

Psychiatry

1,217

$87.5K

150
68 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $143

ANANTH SHANMUGAM MD, PH.D

Psychiatry

1,127

$112K

292
0 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $143

ANIL PATEL MD

Psychiatry

2,522

$218K

193
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $143

HELEN CRAWFORD MD

Psychiatry

754

$103K

68
57 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $143

KEKOA EDE MD

Psychiatry

5,214

$385K

271
99 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $143

ANDREA HEDIN MD

Psychiatry

945

$180K

107
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 25%

$190
Average prescription price

Avg: $143

RAYMOND MANNING M.D.

Psychiatry

1,309

$187K

123
33 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$143
Average prescription price

Avg: $143

TRENTON MOYER M.D

Psychiatry

3,257

$442K

192
38 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $143

TRAVIS SVENSSON MD, PHD

Psychiatry

3,288

$422K

262
81 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $143

RAJDEEP RANADE M.D.

Psychiatry

953

$123K

212
28 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $143

MICHAEL LARDON M.D.

Psychiatry

3,059

$420K

98
44 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$137
Average prescription price

Avg: $143

LEONARD JONES M.D.

Psychiatry

3,321

$380K

347
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $143

CHRISTOPHER MORACHE MD

Psychiatry

2,465

$466K

113
38 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$189
Average prescription price

Avg: $143

PARAMJIT GILL M.D.

Psychiatry

1,922

$159K

190
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $143

ERIC JACOBSON M.D.

Psychiatry

2,503

$397K

112
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 25%

$158
Average prescription price

Avg: $143

RAYMOND FIDALEO MD

Psychiatry

3,403

$353K

123
37 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $143

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank